Pet Therapy Clinical Trials
- Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00358098 - Recruiting
Metastatic Breast Cancer
- Effects of Pet Therapy on Pain in Cancer Patients
ClinicalTrials.gov Identifier: NCT00103688 - Recruiting
- Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00135161 - Active, not recruiting
neoplasms (squamous cell carcinoma of the head and neck region)
- Tailored Therapy for Hodgkin Lymphoma Using Early Interim Therapy PET for Therapy Decision.
ClinicalTrials.gov Identifier: NCT00392314 - Recruiting
Hodgkin Lymphoma
- A Phase II Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients with Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00123747 - Recruiting
Lung Neoplasms
- PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
ClinicalTrials.gov Identifier: NCT00019565 - Active, not recruiting
Unspecified Adult Solid Tumor, Protocol Specific
- Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00433433 - Recruiting
Lymphoma
- PET Imaging in Post Radiation Evaluation of Head and Neck Tumours "PET PREVENT"
ClinicalTrials.gov Identifier: NCT00147472 - Recruiting
Cancer of the Head and Neck
- F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response
ClinicalTrials.gov Identifier: NCT00180193 - Recruiting
Brain Tumor
- Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA
ClinicalTrials.gov Identifier: NCT00373711 - Recruiting
Thyroid Cancer
- PET Imaging of Brain mGluR5 Receptors Using [18F]SP203
ClinicalTrials.gov Identifier: NCT00538798 - Recruiting
Glutamate Receptor; mGlur5 Protein; Excitatory Amino Acid Receptors; Drug Kinetics; PET Scan
- A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer
ClinicalTrials.gov Identifier: NCT00480246 - Recruiting
Healthy
- Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET
ClinicalTrials.gov Identifier: NCT00188149 - Recruiting
Hodgkin Disease
- PET Imaging in Potentially Surgically Resectable Non-Small Cell Lung Cancers (ELPET Trial)
ClinicalTrials.gov Identifier: NCT00136890 - Active, not recruiting
Non-Small-Cell Lung Carcinoma
- PET Imaging in Stage III Non-Small Cell Lung Cancer (PET START Trial)
ClinicalTrials.gov Identifier: NCT00136864 - Recruiting
Non-Small-Cell Lung Carcinoma
- Quantification of pulmonary neutrophil activity in cystic fibrosis using radiolabeled fluorodeoxyglucose and PET imaging
ClinicalTrials.gov Identifier: NCT00023465 - Recruiting
Cystic Fibrosis
- PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer
ClinicalTrials.gov Identifier: NCT00362973 - Recruiting
Breast Cancer
- Exploratory Study Evaluation FDG-PET as a Predictive Marker for Therapy With RAD 001 in Metastatic Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00529802 - Recruiting
Carcinoma, Renal Cell
- PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery
ClinicalTrials.gov Identifier: NCT00004891 - Active, not recruiting
stage II rectal cancer; stage III rectal cancer; Stage IV rectal cancer
- Validation of 18F-MISO-PET and 18F-FLT-PET
ClinicalTrials.gov Identifier: NCT00159978 - Recruiting
Head and Neck Neoplasms
- The Use of Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) to Assess the Effects of Anti-Neoplastic Therapy on Tumor Associated Vasculature
ClinicalTrials.gov Identifier: NCT00001709 - Recruiting
Neoplasm
- Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET
ClinicalTrials.gov Identifier: NCT00180245 - Recruiting
Head and Neck Cancer
- Cardiac Water and Fluoromethane PET
ClinicalTrials.gov Identifier: NCT00205127 - Active, not recruiting
Healthy Volunteers
- Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer
ClinicalTrials.gov Identifier: NCT00416455 - Recruiting
Cervical Cancer
- Hormone Therapy in Treating Patients With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003026 - Active, not recruiting
adenocarcinoma of the prostate
- Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors
ClinicalTrials.gov Identifier: NCT00163176 - Recruiting
Head and Neck Neoplasms
- Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
refractory plasma cell neoplasm
- Early on-Therapy PET at First-Line Treatment in Diffuse Large B-Cell Lymphoma Stage IIB-IV
ClinicalTrials.gov Identifier: NCT00286832 - Recruiting
Diffuse Large-Cell Lymphoma
- Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
ClinicalTrials.gov Identifier: NCT00004024 - Active, not recruiting
adult brain tumor
- Para-Aortic Lymph Nodal Staging and Evaluation of Treatment Outcome by 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in Advanced Cancer Cervix
ClinicalTrials.gov Identifier: NCT00193752 - Recruiting
Cancer of Cervix; Cervical Cancer; Cancer of the Cervix; Cervix Cancer
- Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00023959 - Active, not recruiting
Head and Neck Cancer
- PET Imaging of Regional Variation in Insulin Sensitivity of Adipose Tissue in Humans
ClinicalTrials.gov Identifier: NCT00222768 - Active, not recruiting
Diabetes; Obesity
- PET Scans and CT Scans in Treating Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
ClinicalTrials.gov Identifier: NCT00388024 - Recruiting
Head and Neck Cancer; Unclassified and Other Cancer
- Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
ClinicalTrials.gov Identifier: NCT00006480 - Active, not recruiting
disseminated neuroblastoma; Drug Toxicity; recurrent neuroblastoma
- PET-CT Scan as a Diagnostic Method in Unknown Primary Tumors
ClinicalTrials.gov Identifier: NCT00269373 - Recruiting
Unknown Primary Tumor
- SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
- Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases
ClinicalTrials.gov Identifier: NCT00033254 - Active, not recruiting
brain metastases
- PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)
ClinicalTrials.gov Identifier: NCT00201942 - Completed
Breast Cancer
- Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00055913 - Active, not recruiting
Head and Neck Cancer
- Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00005034 - Active, not recruiting
intraocular melanoma; Melanoma
- Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00014560 - Active, not recruiting
Lymphocytic Lymphoma; Non-Hodgkin's Lymphoma
- Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00082823 - Active, not recruiting
Cancer
- Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00083213 - Active, not recruiting
Cancer
- Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00006385 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer
ClinicalTrials.gov Identifier: NCT00007904 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer
- Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma
ClinicalTrials.gov Identifier: NCT00002560 - Active, not recruiting
recurrent neuroblastoma
- Enzastaurin in Treating Patients With Recurrent Gliomas
ClinicalTrials.gov Identifier: NCT00112788 - Active, not recruiting
adult brain tumor
- Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00128700 - Active, not recruiting
adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
- Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00182689 - Active, not recruiting
Lung Cancer
- Biological Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002786 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Biological Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00045149 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00067015 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer; Quality of Life
- Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00096512 - Active, not recruiting
Head and Neck Cancer
- Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/neu-Expressing Cancer
ClinicalTrials.gov Identifier: NCT00084513 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00091299 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- The Role of FLT-PET in Proliferation of Colorectal Livermetastases
ClinicalTrials.gov Identifier: NCT00145665 - Recruiting
Colorectal Neoplasms; Liver Neoplasms; Recurrence
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00089206 - Active, not recruiting
intraocular melanoma; Melanoma
- The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in Predicting Progression of Non Hodgkins Lymphoma
ClinicalTrials.gov Identifier: NCT00498667 - Active, not recruiting
Agressive B Cells Lymphoma
- Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00028678 - Active, not recruiting
adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
- Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00016913 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer
- Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
ClinicalTrials.gov Identifier: NCT00006734 - Active, not recruiting
localized tumors of the Ewing's family
- Cetuximab, Combination Chemotherapy, and Radiation therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00109850 - Active, not recruiting
Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage III esophageal cancer
- Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00003456 - Active, not recruiting
adult glioblastoma
- Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00006113 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003653 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00084708 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00104884 - Active, not recruiting
intraocular melanoma; Melanoma
- Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00040950 - Active, not recruiting
adult non-Hodgkin's lymphoma
- Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00054522 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00015977 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00007826 - Active, not recruiting
Colon Cancer; Rectal Cancer
- Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
ClinicalTrials.gov Identifier: NCT00003414 - Active, not recruiting
Lymphoma
- Sorafenib in Treating Patients with Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00119249 - Active, not recruiting
Stage IV Melanoma
- GW786034 in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00060151 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00005959 - Active, not recruiting
Lymphoma
- Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00089219 - Active, not recruiting
intraocular melanoma; Melanoma
- Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00089115 - Active, not recruiting
grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma
- Combination Chemotherapy in Treating Women With Stage I Breast Cancer
ClinicalTrials.gov Identifier: NCT00055679 - Active, not recruiting
stage I breast cancer
- Brief Strategic Family Therapy for Adolescent Drug Abusers - 1
ClinicalTrials.gov Identifier: NCT00095303 - Active, not recruiting
Behavior Therapy
- Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
ClinicalTrials.gov Identifier: NCT00004227 - Active, not recruiting
Oral Cancer; Throat Cancer
- Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00060398 - Active, not recruiting
recurrent prostate cancer; Anemia; Fatigue
- Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00058006 - Active, not recruiting
Head and Neck Cancer; thorax and respiratory cancer
- Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00005044 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
- Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
ClinicalTrials.gov Identifier: NCT00217620 - Active, not recruiting
adult soft tissue sarcoma
- Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas
ClinicalTrials.gov Identifier: NCT00003113 - Active, not recruiting
Lymphoma
- Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00098475 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- PEG-Interferon alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00090870 - Active, not recruiting
Stage IV Renal Cell Cancer
- Sorafenib With or Without Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00126594 - Active, not recruiting
renal clear cell carcinoma; Stage IV Renal Cell Cancer
- Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00053768 - Active, not recruiting
adult non-Hodgkin's lymphoma
- Tipifarnib in Treating Patients With Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00060125 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of the HER2/neu Protein
ClinicalTrials.gov Identifier: NCT00004074 - Active, not recruiting
Cancer
- Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00012233 - Active, not recruiting
Stage IV rectal cancer; stage IV colon cancer
- Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00080873 - Active, not recruiting
Cancer; oral complications of cancer and cancer therapy
- Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00126490 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Interleukin-12 and Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00026143 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors
ClinicalTrials.gov Identifier: NCT00003478 - Active, not recruiting
adult brain tumor
- ZD6474 and Docetaxel in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00054093 - Active, not recruiting
Non-small cell lung cancer
- Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00049296 - Active, not recruiting
Cancer
Resources
- Pet Therapy (National Women's Health Information Center)
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
